Medical Risks and Benefit of Pancreas Transplants from Living Related Donors

  • D. E. R. Sutherland
  • F. C. Goetz
  • K. Gillingham
  • K. C. Moudry-Munns
  • J. S. Najarian


The rationale to perform transplants of any organ from living related donors (LRDs) rather than cadaver (Cad) donors is two-fold: there is a shortage of Cad donors for the number in need of a transplant, and the rejection rate will be less with grafts from LRDs. Either reason by itself will justify the use of LRDs, and for kidney transplants both pertain.


Kidney Transplant Pancreas Transplant Bladder Drainage Pancreas Graft Human Leukocyte Antigen Match 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Sutherland DER, Goetz FC, Najarian JS (1984) Pancreas transplants from living related donors. Transplantation 38:6740–679.Google Scholar
  2. 2.
    Sutherland DER, Matas AJ, Goetz FC, Najarian JS (1990) Transplantation of dispersed pancreatic islet tissue in humans: autografts and allografts. Diabetes 29 [Suppl 1]:31–44.Google Scholar
  3. 3.
    Sutherland DER, Goetz FC, Rynasiewicz JJ, et al (1981) Segmental pancreas transplantation from living related and cadaver donors: a clinical experience. Surgery 90:159–169.Google Scholar
  4. 4.
    Barbosa J, King R, Goetz FC, et al (1977) Histocompatibility antigens (HLA) in families with juvenile insulin dependent diabetes mellitus. J Clin Invest 60:989–999.CrossRefGoogle Scholar
  5. 5.
    Kendall DM, Sutherland DER, Goetz FC, Najarian JS (1989) Metabolic effect on hemipancreatectomy in donors: preoperative prediction of postoperative oral glucose tolerance. Diabetes 38 [Suppl 1]:101–103.Google Scholar
  6. 6.
    Kendall DM, Sutherland DER, Najarian JS, Goetz FC, Robertson RP (1990) Effects of hemi-pancreatectomy on insulin secretion and glucose tolerance in healthy human donors. N Engl J Med 322:898–903.CrossRefGoogle Scholar
  7. 7.
    Seaquist ER, Robertson RP (1990) Metabolic effects of hemipancreatectomy on human donors. Clin Res 38:156A.Google Scholar
  8. 8.
    Seaquist ER, Robertson RP (1990) Metabolic effects of hemipancreatectomy on human donors. Diabetes 39 [Suppl 1]:5A.Google Scholar
  9. 9.
    Morel P, Gillingham KJ, Moudry Munns KC, Dunn DL, Najarian JS, Sutherland DER (1991) Factors influencing pancreas transplant outcome: Cox Proportional Hazard Regression Analysis of a single institution’s experience with 357 cases. Transplant Proc 23(1):1630–1633.Google Scholar
  10. 10.
    Sutherland DER, Sibley R, Zhu X-Z, Michael A, Srikanta S, Taub F, Najarian JS, Goetz FC (1984) Twin-to twin pancreas transplantation: reversal and reenactment of the pathogenesis of Type I diabetes. Transplant Assoc Amer Phys XCVII:80–87.Google Scholar
  11. 11.
    Sibley RK, Sutherland DER, Goetz F, Michael AF (1985) Recurrent diabetes mellitus in the pancreas iso-and allograft. A light and electron microscopic and immunohisto-chemical analysis of four cases. Lab Invest 53:132–144.Google Scholar
  12. 12.
    Sutherland DER, Sibley RK (1988) Recurrence of disease in pancreas transplants. In: van Schilfgaarde R, Hardy MA (eds) Transplantation of the endocrine pancreas in diabetes mellitus. Elsevier, Amsterdam, pp. 60–66.Google Scholar
  13. 13.
    Sutherland DER, Goetz FC, Sibley RK (1989) Recurrence of disease in pancreas transplants. Diabetes 38 [Suppl 1]:85–87.Google Scholar
  14. 14.
    Eisenbarth GS (1986) Type I diabetes mellitus: a chronic autoimmune disease. N Engl J Med 314:1360–1368.CrossRefGoogle Scholar
  15. 15.
    Sutherland DER, Goetz FC, Elick BA, Najarian JS (1982) Experience with 49 segmental pancreas transplants in 45 diabetic patients. Transplantation 34:330–338.CrossRefGoogle Scholar
  16. 16.
    Sibley RK, Sutherland DER (1987) Pancreas transplantation: an immunohistologic and histopathologic examination of 100 grafts. Am J Pathol 128:151–170.Google Scholar
  17. 17.
    Squifflet JP, Moudry K, Sutherland DER (1988) Is HLA matching relevant in pancreas transplantation? Transplant Int 1:26–29.Google Scholar
  18. 18.
    So SKS, Moudry-Munns KC, Gillingham K, Minford EJ, Sutherland DER (1991) Short-term and long-term effects of HLA matching in cadaveric pancreas transplantation. Transplant Proc 23(1): 1634–1636.Google Scholar
  19. 19.
    Sutherland DER, Moudry-Munns KC, Gillingham K (1990) Pancreas transplantation. Report from the International Registry and a preliminary analysis of United States results from the new United Network for Organ Sharing (UNOS) registry. In: Terasaki, P (ed) Clinical transplants 1989. UCLA Tissue Typing Laboratory, Los Angeles, pp. 253–266.Google Scholar
  20. 20.
    So SKS, Minford EJ, Moudry-Munns KC, Gillingham K, Sutherland DER (1990) DR matching improves cadaveric pancreas transplant results. Transplant Proc 22(2):687–688.Google Scholar
  21. 21.
    Sutherland DER, Dunn DL, Goetz FC, et al (1989) A ten year experience with 290 pancreas transplants at a single institution. Ann Surg 210:274–288.CrossRefGoogle Scholar
  22. 22.
    Groth CG, Tyden G, Ostman J (1989) Fifteen years’ experience with pancreas transplantation with pancreaticoenterostomy. Diabetes 38 [Suppl 1]:13.Google Scholar
  23. 23.
    Bolinder J, Gunnarsson R, Tyden G, Brattstrom C, Ostman J, Groth CG (1988) Metabolic effects of living related pancreatic graft donation. Transplant Proc 20 (3):475-478.Google Scholar
  24. 24.
    Sutherland DER (1985) Living related donors should be used whenever possible. Transplant Proc 17:1503–1509.Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1991

Authors and Affiliations

  • D. E. R. Sutherland
    • 1
  • F. C. Goetz
    • 1
  • K. Gillingham
    • 1
  • K. C. Moudry-Munns
    • 1
  • J. S. Najarian
    • 1
  1. 1.University of Minnesota Hospital and ClinicMinneapolisUSA

Personalised recommendations